Design Therapeutics Ownership | Who Owns Design Therapeutics?

Design Therapeutics Ownership Summary

Design Therapeutics is owned by 70.93% institutional investors, 31.87% insiders. Sr one capital management, lp is the largest institutional shareholder, holding 10.62% of DSGN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.86% of its assets in Design Therapeutics shares.

DSGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Design Therapeutics	70.93%	31.87%	-2.80%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sr one capital management, lp	6.53M	10.62%	$94.44M
Durable capital partners lp	3.46M	6.12%	$334.67M
Conestoga capital advisors	3.12M	5.52%	$301.76M
Jarislowsky, fraser	2.89M	5.12%	$279.97M
Logos global management lp	3.00M	4.88%	$43.41M
Fiera capital	2.56M	4.53%	$248.02M
Baker bros. advisors lp	2.68M	4.36%	$38.76M
Driehaus capital management	2.66M	4.33%	$38.51M
Blackrock funding, inc. /de	2.66M	4.33%	$38.49M
Primecap management co/ca/	2.24M	3.96%	$216.78M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sr one capital management, lp	6.53M	9.09%	$94.44M
Zeno equity partners llp	266.28K	6.86%	$25.79M
Conestoga capital advisors	3.12M	4.52%	$301.76M
Herald investment management	230.00K	3.65%	$22.24M
Almitas capital	1.03M	3.56%	$14.86M
Summit creek advisors	258.25K	3.43%	$25.01M
Acuta capital partners	282.56K	2.85%	$4.09M
Durable capital partners lp	3.46M	2.75%	$334.67M
Geneva capital management	1.46M	2.57%	$141.16M
Triasima portfolio management	253.85K	2.25%	$24.58M

Top Buyers

Holder	Shares	% Assets	Change
Frazier life sciences management	1.81M	0.57%	1.81M
Congress asset management co /ma	1.22M	0.85%	1.22M
Norges bank	1.12M	0.02%	1.12M
Logos global management lp	3.00M	1.87%	1.05M
Caption management	1.12M	0.08%	1.03M

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-2.97M
Kynam capital management, lp	-	-	-784.61K
Arrowstreet capital, limited partnership	611.83K	0.05%	-633.32K
Almitas capital	1.03M	3.56%	-503.44K
Jarislowsky, fraser	2.89M	1.70%	-438.99K

New Positions

Holder	Shares	% Assets	Change	Value
Congress asset management co /ma	1.22M	0.85%	1.22M	$118.30M
Norges bank	1.12M	0.02%	1.12M	$108.88M
Sofinnova investments	865.13K	0.65%	865.13K	$12.52M
Siren	523.21K	0.15%	523.21K	$7.57M
Sixth street partners management company	271.26K	0.00%	271.26K	$3.93M

Sold Out

Holder	Change
Fairman group	-8.00
Mai capital management	-8.00
Financial gravity asset management	-11.00
Harbour investments	-12.00
Spire wealth management	-18.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	140	12.90%	43,576,236	14.71%	70	1.62%	92	17.95%	31	10.71%
Mar 31, 2026	44	-62.71%	3,148,091	-91.74%	5	0.12%	27	-61.43%	8	-72.41%
Dec 31, 2025	63	-32.98%	15,972,316	-53.69%	28	0.76%	29	-19.44%	19	-42.42%
Sep 30, 2025	78	-8.24%	25,324,931	-22.71%	44	1.34%	25	-35.90%	31	10.71%
Jun 30, 2025	90	-8.16%	34,511,542	0.15%	60	1.65%	39	5.41%	33	-17.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.16M	1.86%	176.30K
Vanguard Morn Total Stk Mkt Idx Investor	1.16M	1.86%	176.30K
Vanguard MStar Total Stk Mkt Idx Invest	1.16M	1.86%	-
Vanguard US Total Market Shares ETF	800.90K	1.41%	-
iShares Russell 2000 ETF	798.62K	1.28%	-14.21K
Fidelity Select Biotechnology	534.93K	0.86%	-
Vanguard Institutional Extnd Mkt Idx Tr	374.52K	0.60%	766.00
Heptagon Driehaus US Micro Cap Eq C$ Acc	348.60K	0.56%	-
State St Russell Sm/Mid Cp® Indx NL Cl C	269.86K	0.48%	-
iShares Russell 2000 Growth ETF	281.99K	0.45%	-2.58K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 13, 2025	William Arsani	-	Sell	$1.14M
Aug 13, 2025	William Arsani	-	Sell	$1.81M
Dec 18, 2024	Prasad Deepa	-	Sell	$23.86K
Aug 09, 2024	William Arsani	-	Sell	$3.46M
Mar 22, 2024	Schmid John P.	-	Buy	$33.13K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	-
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	2
2025 Q2	-	-

DSGN Ownership FAQ

Who Owns Design Therapeutics?

Design Therapeutics shareholders are primarily institutional investors at 70.93%, followed by 31.87% insiders and -2.80% retail investors. The average institutional ownership in Design Therapeutics's industry, Biotech Stocks , is 379.01%, which Design Therapeutics falls below.

Who owns the most shares of Design Therapeutics?

Design Therapeutics’s largest shareholders are Sr one capital management, lp (6.53M shares, 10.62%), Durable capital partners lp (3.46M shares, 6.12%), and Conestoga capital advisors (3.12M shares, 5.52%). Together, they hold 22.26% of Design Therapeutics’s total shares outstanding.

Does Blackrock own Design Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Design Therapeutics.

Who is Design Therapeutics’s biggest shareholder by percentage of total assets invested?

Sr one capital management, lp is Design Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.09% of its assets in 6.53M Design Therapeutics shares, valued at 94.44M$.

Who is the top mutual fund holder of Design Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Design Therapeutics shares, with 1.86% of its total shares outstanding invested in 1.16M Design Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools